SHS I

ROTOP is a pharmaceutical company specializing in the manufacture of cGMP-compliant radiopharmaceuticals for use in nuclear medicine diagnostics and therapy. They provide a range of services including the synthesis of active pharmaceutical ingredients (APIs), development of analysis kits, project management, and comprehensive regulatory support. Additionally, ROTOP offers sterile kits for radiolabeled pharmaceuticals and contract research services, enabling clients to enhance the efficiency and effectiveness of their diagnostic and therapeutic processes. Their customer engagement is facilitated through direct communication channels.

Medical Technology Rostock supplies erection aids, compression, and electrotherapy devices.

Develco Pharma Schweiz is pharmaceutical manufacturing company produce formulations of drugs, health care, medicine.

Essert is a developer of robotic systems and augmented automation solutions aimed at driving digital transformation across various industries. The company specializes in modular and flexible robot workstations and human-robot collaboration systems. By providing digital management services, Essert enables electronic and other sectors to enhance productivity and improve the quality of their processes. The company fosters a culture of community and open communication, striving to set and achieve new sustainability goals in a technologically advanced environment.

CAM Bioceramics specializes in the design, development, and manufacturing of orthobiologic calcium phosphates, which are essential materials in the medical technology and life sciences sectors. The company's product lineup includes hydroxyapatite, α-TCP, β-TCP, and Biphasic HA and TCP, available in various forms such as coating powders, specialty powders, granules, and blocks. CAM Bioceramics also offers customized solutions to meet specific client needs. Through robust quality management systems, the company ensures its products comply with regulatory requirements, ultimately supporting clients in the orthopedic, dental, and aesthetic fields to enhance patient outcomes affordably.

MESI is a developer of predictive medical assessment devices aimed at enhancing diagnostics in primary care and facilitating earlier disease detection. The company's flagship product, the MESI mTABLET, is an FDA and CE marked platform that integrates artificial intelligence and marketplace capabilities to assist clinicians in providing more efficient medical assessments. Among its offerings is a device that measures the ankle-brachial pressure index, which allows healthcare professionals to screen for peripheral artery disease in older patients using the oscillometric method. This technology simplifies the diagnostic process and improves the quality of care in ambulatory healthcare settings.

Simulands is a medical simulation company dedicated to enhancing patient outcomes through innovative training solutions. The company specializes in developing and commercializing advanced simulation systems for healthcare education, focusing on cost-effective and ethical practices that surpass traditional training methods. Simulands provides expertise in medical device development and employs novel manufacturing techniques to create simulators that closely replicate human cardiovascular systems. This approach enables more practical animal research practices while adhering to the standards set by relevant authorities, ethics committees, and notified bodies. By prioritizing realistic training experiences, Simulands aims to advance the effectiveness and ethical considerations of medical education.

Dr.Dropin is a modern private healthcare service that aims to make medical care accessible and affordable. The company operates a comprehensive digital platform that offers a wide array of medical services, including general medicine, specialist consultations, dermatology, physical therapy, and psychological support. By providing a one-stop shop for various healthcare needs, Dr.Dropin enables patients to access essential services both physically and digitally. The platform is designed to democratize the private healthcare market, ensuring that patients can receive timely care at fixed prices, thereby enhancing the overall patient experience.

PathoQuest SAS is a biotechnology company that specializes in advanced metagenomics for pathogen detection, having originated as a spin-off from Institut Pasteur. The company utilizes proprietary next-generation sequencing (NGS) technology, which combines innovative sample preparation with a comprehensive database of pathogen genomic information. This approach allows clinicians and biopharmaceutical professionals to enhance the detection of infectious agents in various biological samples. PathoQuest's Viral Safety testing service, aimed at biopharmaceutical companies, represents its first commercial application and has rapidly generated revenue from major industry players. The company's cloud-based bioinformatics platform and automated analysis pipeline further facilitate improved pathogen detection, making its solutions valuable for both clinical and biopharmaceutical quality assurance.

Incision is a developer of a medical education platform designed to provide a standardized approach to performing medical procedures through a series of practical steps and sub-steps. The platform facilitates access to shared experiences, skills, and expertise, enabling medical students to achieve rapid and thorough preparation for their roles in the operating room. By focusing on the development of essential competencies and skills, Incision aims to enhance the training of future healthcare professionals.

Salvia BioElectronics B.V., founded in 2017 and headquartered in Eindhoven, the Netherlands, focuses on developing bioelectronic therapies for individuals with chronic neurological conditions, particularly chronic migraines. Drawing its name from the Latin word for "to stay healthy," Salvia is committed to providing drug-free, effective, and side-effect-free solutions. The company leverages a team of experienced professionals, including entrepreneurs, engineers, and scientists, who have extensive backgrounds in the medical device industry. Salvia aims to make its innovative bioelectronic solutions widely accessible, addressing the needs of patients seeking alternative treatments for their conditions.

Neuro Event Labs Oy is a Finnish medical technology company founded in 2015 and based in Tampere. The company specializes in developing artificial intelligence-powered software that monitors epilepsy patients both at home and in clinical settings. Its primary product collects and analyzes accurate data on epilepsy seizures through the use of video and various sensors, leveraging computer vision, smart analytics, and machine learning. This data is relayed to healthcare providers, allowing them to make informed treatment decisions tailored to individual patients. The solution has been crafted in collaboration with leading hospitals in Finland, enhancing its reliability and effectiveness in managing epilepsy care.

Blazejewski MEDI-TECH GmbH, founded in 1991 and based in Emmendingen, Germany, specializes in the development, manufacturing, and distribution of medical endoscopes and visualization units tailored for minimally invasive surgical applications. The company provides a diverse range of products, including rigid and semi-flexible endoscopes, 3D stereoscopy systems, and custom-specific endoscopic solutions, catering to various medical fields such as neurology, spine, ENT, urology, and gynecology. With a focus on quality, Blazejewski MEDI-TECH serves original equipment manufacturers both in Germany and internationally, offering advanced mechanical, electronic, and fiber optical components for enhanced disease diagnosis and inspection services.

Selfapy GmbH is a Berlin-based company that specializes in developing online therapy programs aimed at individuals affected by depression and other psychological disorders. Since its founding in 2016, Selfapy has offered a range of programs addressing issues such as anxiety, eating disorders, stress, and chronic panic. The company provides users with a guided self-help experience, featuring exercises, videos, and texts delivered over a three-month period via phone or SMS. With a focus on recognizing negative thought patterns and promoting new behaviors, Selfapy's anonymous and flexible therapy solutions are designed to support users in managing their mental health effectively.

Single Use Support GmbH, founded in 2015 and headquartered in Kufstein, Austria, specializes in manufacturing heavy-duty single-use plastic containers and packaging products for the transportation of liquids, primarily serving the biopharma industry. The company develops innovative bulk filling systems, including BULK.STREAM and RoSS.FILL, designed to enhance fluid logistics processes and prevent losses due to leakages or bio-contamination. By offering tailored packaging solutions, Single Use Support aims to improve the efficiency and safety of liquid logistics in the pharmaceuticals sector.

GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in innovative diagnostic devices for detecting and analyzing DNA. Their core technology, Pulse Controlled Amplification, enhances molecular testing by integrating ultrafast nucleic acid amplification with intrinsic sample preparation. This advancement allows for efficient and simplified diagnosis of human pathogens in laboratory settings, as well as on-site applications and Point of Care scenarios. GNA Biosolutions aims to make the benefits of molecular testing accessible to a broader audience, facilitating rapid and accurate results from sample collection to analysis.

Betterguards Technology GmbH, founded in 2014 and headquartered in Berlin, Germany, specializes in innovative ankle protection solutions designed for athletes and individuals at risk of injury. The company develops adaptors that can be integrated into shoes, gloves, and other protective gear, offering responsive stabilization for the ankle without restricting movement. This technology aims to prevent injuries from sudden ankle twisting and rolling, making it suitable for sports enthusiasts such as football and basketball players, hikers, and extreme sport participants. Additionally, Betterguards’ products cater to individuals with unstable ankles and elderly people prone to falls due to balance disorders. The company is recognized for its commitment to injury prevention and performance enhancement, having been selected by NBA Launchpad in 2022 to collaborate on ankle injury protection strategies. Betterguards combines advanced German engineering with insights from world-class athletes to deliver effective injury protection solutions.

Evitria AG is a biotechnology company based in Schlieren, Switzerland, specializing in the research, development, and production of protein design and expression products. The firm focuses on CHO-based transient expression of antibodies, including bispecific and fusion antibodies, and offers a robust protein expression platform that facilitates the rapid production of significant quantities of protein using HEK293 and CHO cells. With a proven track record of over 30,000 transfections and more than 5,000 antibodies and antibody-based molecules expressed and purified, Evitria serves a diverse clientele, including academic laboratories, small biotech start-ups, and major biopharmaceutical companies across the Americas, Europe, Asia, and Australia. The company's expertise enables clients to efficiently manage antibody production and address capacity challenges in their projects. Founded in 2010, Evitria continues to provide high-quality services in the field of protein expression and gene transfer.

Miracor Medical is a medical device company focused on developing and commercializing innovative technologies for treating severe cardiac diseases. Established in 2008 and headquartered in Awans, Belgium, the company specializes in the PiCSO Impulse System, which utilizes pressure-controlled intermittent coronary sinus occlusion. This system is designed to aid cardiac surgeons in treating patients who have experienced myocardial infarction, particularly those undergoing coronary artery bypass grafting surgery. The PiCSO treatment aims to enhance microvascular perfusion and improve cardiac function by increasing blood flow to damaged heart tissue, potentially reducing the risk of heart failure following acute myocardial infarction.

CoreMedic AG is a medical technology company based in Biel/Bienne, Switzerland, specializing in the development and manufacturing of devices and therapies for heart valve diseases, particularly mitral valve regurgitation. Founded in 2012 as a spin-out from the Heart Center of the University of Bern, the company has created the ChordArt system, which offers a minimally invasive approach for repairing mitral valves. This system includes ChordArt S, designed to streamline the surgical procedure by allowing surgeons to focus on timing rather than manual suturing, and ChordArt C, which enables repairs through a small incision in the groin. Following successful human trials, CoreMedic is committed to advancing the ChordArt transcatheter mitral valve repair system to improve treatment options for patients suffering from severe mitral regurgitation. The company is positioned within a prominent medical technology cluster in Germany, facilitating collaboration and innovation in the field.

Medigroba GmbH is a healthcare service provider based in Germany, focusing on the care of patients in various settings, including hospitals, nursing facilities, and homes. The company offers a range of auxiliary and care products designed to support clinics, care facilities, nursing homes, and medical practices. Its product offerings include medical care supplies, medical devices, and medical technology, complemented by the services of registered nurses and specialized technicians. Medigroba aims to enhance patient care through its comprehensive service model and quality medical supplies.

Miracor Medical is a medical device company focused on developing and commercializing innovative technologies for treating severe cardiac diseases. Established in 2008 and headquartered in Awans, Belgium, the company specializes in the PiCSO Impulse System, which utilizes pressure-controlled intermittent coronary sinus occlusion. This system is designed to aid cardiac surgeons in treating patients who have experienced myocardial infarction, particularly those undergoing coronary artery bypass grafting surgery. The PiCSO treatment aims to enhance microvascular perfusion and improve cardiac function by increasing blood flow to damaged heart tissue, potentially reducing the risk of heart failure following acute myocardial infarction.

Emerging Implant Technologies specializes in the design and manufacture of orthopedic spinal implants, utilizing advanced additive manufacturing methods such as three-dimensional printing. Founded in 2014 and headquartered in Tuttlingen, Germany, the company develops products including cervical cages and PLIF and TLIF cages. These implants are engineered to promote bone growth after fusion surgeries and aim to reduce complication rates, thereby improving patient outcomes. Since September 2018, Emerging Implant Technologies has operated as a subsidiary of Johnson & Johnson Medical, focusing on innovation in the orthopedic implant sector.

Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

Tyromotion GmbH is a manufacturer and distributor of robotic-assisted and computer-aided therapy units, focusing on rehabilitation technologies that utilize mechatronic systems. Founded in 2007 and headquartered in Graz, Austria, with an additional office in New York City, the company is known for its development of the Amadeo System, a mechatronic rehabilitation device designed for patients with motor dysfunctions of the distal upper extremity. In addition to the Amadeo System, Tyromotion creates a comprehensive range of devices that incorporate virtual reality and gamification to enhance rehabilitation for both upper and lower extremities, addressing neurologic and orthopedic conditions. These innovations aim to improve users' independence and quality of life during their rehabilitation process.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Puracon is a provider of medical packaging and logistics services headquartered in Rosenheim, Germany. Established in 2003, the company specializes in sterile packaging solutions for the medical technology, pharmacology, and biotechnology sectors. Puracon offers a comprehensive range of services, including contract packaging, which encompasses inspection, cleaning, assembly, sterilization, and validation of medical products. Additionally, it provides logistics services such as storage and shipping, as well as consulting services to support product approvals. By focusing on conformity, efficiency, and safety, Puracon assists its clients in navigating the complexities of medical product compliance and distribution. The company operates as a subsidiary of KLINGEL medical metal GmbH.

SIS SCHWAGER Group through its subsidiaries develops, produces, and sells products for the treatment of vascular disease. It began operation in 2005, with its headquarters in Winterthur in Switzerland.

NDD Medizintechnik AG specializes in the manufacture of pulmonary function testing products, providing a range of innovative spirometry solutions. Its product lineup includes the EasyOne World spirometer, a portable device for testing, and the EasyOne Pro LAB, which combines spirometry with single-breath carbon monoxide diffusion and multi-breath nitrogen washout capabilities. The company also offers the EasyOne Pro for spirometry and single-breath carbon monoxide diffusion, the EasyOne-Line for direct PC connectivity, and the Easy on-PC for PC-based spirometry. Additionally, NDD Medizintechnik supplies various accessories, such as disposable spirettes and barriers, to support its testing equipment. Founded in 1992, the company is headquartered in Zurich, Switzerland, and markets its products through dealers and online channels both domestically and internationally.

Novo Klinik-Service GmbH is a company based in Kerpen, Germany, that specializes in the development and production of fixations and pads for the intensive care, anesthetic, and nursing sectors, both domestically and internationally. The company provides a range of products, including tracheostomy and laryngectomy fixations and accessories, ventilation fixations and accessories, securement devices, and prophylactic solutions. Additionally, it offers the Novobil One, an ultra-light trolley designed to fit in various elevators, and ITS-Novo, a modular patient room specifically for intensive care settings. Established in 1987, Novo Klinik-Service has built a reputation for innovation and quality in medical equipment.

Arzneimittelwerk Warngau develops and markets drug delivery systems. Its portfolio includes active ingredient/biodegradable implants and transdermal systems in the areas of oncology, pain therapy, and neurology. It focuses on transdermal passive and microchip controlled patches, as well as subcutaneous biodegradable implants. Wilfried Fischer founded Arzneimittelwerk Warngau in 2008. It has its headquarters in Warngau in Germany.

GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in innovative diagnostic devices for detecting and analyzing DNA. Their core technology, Pulse Controlled Amplification, enhances molecular testing by integrating ultrafast nucleic acid amplification with intrinsic sample preparation. This advancement allows for efficient and simplified diagnosis of human pathogens in laboratory settings, as well as on-site applications and Point of Care scenarios. GNA Biosolutions aims to make the benefits of molecular testing accessible to a broader audience, facilitating rapid and accurate results from sample collection to analysis.

Les Delices des 7 Vallees is a privately held company based in Tincques, France, specializing in the production of frozen cakes and pastries. Founded in 1996, the company focuses on manufacturing high-quality frozen patisserie products. As of December 2018, it operates as a subsidiary of Mademoiselle Desserts SAS.

Advanced Osteotomy Tools AG is a Swiss company focused on developing innovative medical devices for osteotomy, a surgical procedure that involves cutting and reshaping bones. Established in 2010 and based in Basel, the company specializes in a computer-assisted and robot-guided laser osteotome device designed for precise functional geometrical bone cuts. This technology is applicable in cranio-maxillofacial interventions and various complex surgical procedures. Advanced Osteotomy Tools AG originated from the University Hospital and the University of Basel, transitioning into a privately owned entity in 2011, with its first funding secured in 2012. The company's mission is to advance bone surgery by utilizing laser technology, robotics, and navigation systems for a contact-free surgical experience.

Miracor Medical is a medical device company focused on developing and commercializing innovative technologies for treating severe cardiac diseases. Established in 2008 and headquartered in Awans, Belgium, the company specializes in the PiCSO Impulse System, which utilizes pressure-controlled intermittent coronary sinus occlusion. This system is designed to aid cardiac surgeons in treating patients who have experienced myocardial infarction, particularly those undergoing coronary artery bypass grafting surgery. The PiCSO treatment aims to enhance microvascular perfusion and improve cardiac function by increasing blood flow to damaged heart tissue, potentially reducing the risk of heart failure following acute myocardial infarction.

Vimecon GmbH, founded in 2005 and headquartered in Herzogenrath, Germany, specializes in the development and production of laser catheters specifically designed for the treatment of heart diseases, with a primary focus on atrial fibrillation. The company also manufactures a range of products for the medical technology and biotechnology sectors, including microscopically small catheters and micro materials handling techniques that facilitate precise measurement and dosage. Additionally, Vimecon provides advisory services to various clients in both academic and industrial research and development. Its innovations aim to enhance healthcare outcomes and support advancements in the treatment of cardiovascular diseases and cardiac arrhythmias.

TRI Dental Implants is a Swiss company that specializes in the design, development, and manufacture of dental implant systems. Founded in 2010 by Tobias S. Richter, the company offers a comprehensive range of products, including soft tissue concepts, friction and bone adaptation systems, as well as various implant types such as narrow and octa implants. Their product line also features a prosthetic portfolio and surgical kits tailored for dental professionals. TRI Dental Implants utilizes a touchless delivery concept, allowing dentists to efficiently pick up implants directly with a surgical handpiece. The company distributes its products through a network of distributors across multiple countries, including Australia, China, and various European nations, while also selling directly to customers in Germany, Italy, France, Hungary, and the United Kingdom. Customers can conveniently place orders online or contact the company via email or phone. The headquarters of TRI Dental Implants is located in Baar, Switzerland.

Miracor Medical is a medical device company focused on developing and commercializing innovative technologies for treating severe cardiac diseases. Established in 2008 and headquartered in Awans, Belgium, the company specializes in the PiCSO Impulse System, which utilizes pressure-controlled intermittent coronary sinus occlusion. This system is designed to aid cardiac surgeons in treating patients who have experienced myocardial infarction, particularly those undergoing coronary artery bypass grafting surgery. The PiCSO treatment aims to enhance microvascular perfusion and improve cardiac function by increasing blood flow to damaged heart tissue, potentially reducing the risk of heart failure following acute myocardial infarction.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

Spiegelberg is a medical equipment company based in Hamburg, Germany, established in 1986. The company specializes in the development, production, and sale of devices for neurosurgical applications, including intracranial pressure monitors, probes, catheters, and external ventricular drain kits. Additionally, Spiegelberg offers antimicrobial products designed to prevent hospital-acquired infections. By focusing on safety in diagnosis and minimally invasive treatments, Spiegelberg aims to enhance patient health outcomes.

Phenox specializes in developing and producing medical products for neuroradiology and radiology, focusing on treatments for acute ischemic strokes and aneurysms. The company's product range includes various instruments such as PCR, CRC, BONNET, and p64 Flow Modulation Devices, which facilitate blood flow restoration and thrombectomy procedures. Additionally, Phenox offers implants for hemorrhagic strokes, including flow diverters and steerable guidewires. With a commitment to enhancing patient safety, the company incorporates advanced hydrophilic polymer coating technology to reduce thrombogenicity in its devices. Established in 2005, Phenox is headquartered in Bochum, Germany, and distributes its innovative products both locally and internationally.

TNI medical AG specializes in developing, producing, and marketing diagnostic and therapeutic equipment for respiratory assistance therapy. The company’s primary product, the TNI SoftFlow System, is designed to provide comprehensive respiratory support while maximizing patient comfort. TNI medical also offers a range of related equipment, including breathing masks and air humidifiers. The company operates from its sites in Würzburg, Dessau, and Baltimore, and was founded in 2007, with its headquarters located in Würzburg, Germany. As of March 2020, TNI medical functions as a subsidiary of Masimo Corporation.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

Biontis GmbH specializes in developing automated processes for the biochemical analysis of complex liquid mixtures and manufactures a range of laboratory equipment. Founded in 2002 and based in Geesthacht, Germany, the company provides essential tools for laboratories involved in water analysis, food inspections, forensic medicine, and clinical diagnostics. Biontis offers a comprehensive array of products, including analytical procedures, test kits, SPE columns, reagents, and automation devices, all designed to facilitate efficient and innovative analytical processes. By streamlining treatment steps such as evaporation, heating, and dissolution, Biontis enables researchers to conduct more effective and cost-efficient analyses. The company's products are marketed primarily in Germany.

c-LEcta is a biotechnology company based in Leipzig, Germany, specializing in enzyme engineering and bioprocess development for regulated markets, including food and pharmaceuticals. Founded in 2004 by Marc Struhalla and Thomas Greiner-Stöffele, the company focuses on developing and commercializing application-oriented enzyme variants, either independently or in collaboration with industry partners. c-LEcta provides customized enzymes and microbial strains, emphasizing cost-efficient and sustainable production processes. Notable products include DENARASE, a genetically engineered endonuclease that aids in the removal of nucleic acids and viscosity reduction, and CalB Immo Plus, an immobilized preparation of the enzyme CalB. Through its innovative solutions, c-LEcta supports clients in making new discoveries and enhancing their market presence.

Micropelt is a startup that emerged from a collaborative project between Infineon Technologies AG and the Fraunhofer Institute for Physical Measurement Techniques in Germany. The company specializes in developing thin film thermoelectric components through semiconductor manufacturing processes. Micropelt focuses on creating energy-harvesting systems that integrate micro-actuators and sensors. Its product offerings include thermoelectric cooling chips and thermoelectric generators designed for various applications, such as chip spot cooling, biomedical devices, heating, ventilation, and air conditioning systems, as well as fiber optics. These innovations aim to facilitate effective temperature management in individual rooms while contributing to CO2 reduction and enhancing user comfort. The company has secured funding from several financial institutions, enabling its growth and development within the thin-film technology sector.

CryLaS Crystal Laser Systems GmbH specializes in designing and manufacturing diode-pumped solid-state lasers across the ultraviolet, visible, and infrared spectrum. Established in 2004 and headquartered in Berlin, Germany, the company focuses on lasers that are utilized in various applications such as spectroscopy, environmental technology, analysis, and photolithography. Its product range includes both pulsed and continuous-wave lasers, which are known for their compactness, reliability, and low operational costs. CryLaS serves a global market, distributing its products through partnerships in numerous countries including Germany, the United States, Canada, and several nations across Europe and Asia. The company's technology supports industries like biotechnology, analytics, imaging, sensor systems, and micromachining.

Salvia BioElectronics B.V., founded in 2017 and headquartered in Eindhoven, the Netherlands, focuses on developing bioelectronic therapies for individuals with chronic neurological conditions, particularly chronic migraines. Drawing its name from the Latin word for "to stay healthy," Salvia is committed to providing drug-free, effective, and side-effect-free solutions. The company leverages a team of experienced professionals, including entrepreneurs, engineers, and scientists, who have extensive backgrounds in the medical device industry. Salvia aims to make its innovative bioelectronic solutions widely accessible, addressing the needs of patients seeking alternative treatments for their conditions.